Key result
SENCR was downregulated in CHD patients, and its overexpression significantly inhibited HA-VSMCs proliferation and migration via the miR-4731-5p/FOXO3a pathway.
Why the study?
Vascular smooth muscle cell proliferation and migration drive atherosclerosis, and the role and downstream regulatory mechanisms of lncRNA SENCR in this context and in patients with coronary heart disease remained to be clarified.
The lncRNA SENCR is downregulated in CHD and inhibits vascular smooth muscle cell proliferation and migration via the miR-4731-5p/FOXO3a pathway, suggesting a potential therapeutic target for atherosclerosis.
Hypothesis-generating for SENCR modulation in atherosclerosis; leaves open translation from preclinical models to clinical use.
The proliferation and migration of vascular smooth muscle cells (VSMCs) are one of the key regulatory links of atherosclerosis (AS). Long noncoding RNAs (lncRNAs) are emerging as key regulators in AS development. In this study, we first assessed the expression level of smooth muscle and endothelial cell-enriched migration/differentiation-associated lncRNA (SENCR) in the plasma of patients with coronary heart disease (CHD) and its predictive and diagnostic value. Second, we investigated the role of SENCR in the regulation network of human aortic-VSMCs (HA-VSMCs) proliferation and migration and determined its downstream regulatory mechanism. The results showed that SENCR was downregulated in the peripheral blood of CHD, and negatively related to the Gensini score. SENCR was enriched in HA-VSMCs and mainly distributed in cytoplasm. Overexpression of SENCR significantly inhibited HA-VSMCs proliferation, migration, and block cell cycle, while the knockdown of SENCR had the opposite effects. Moreover, bioinformatics analysis and luciferase reporter assay demonstrated that miR-4731-5p could directly bind to SENCR. Besides, we proved that FOXO3a inhibited HA-VSMCs proliferation and migration by binding to the 3'-untranslated region of miR-4731-5p. In summary, our research suggested that SENCR affects HA-VSMCs proliferation and migration via regulating the miR-4731-5p/FOXO3a pathway.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2020) studied Coronary heart disease. SENCR expression was evaluated on HA-VSMCs proliferation and migration. SENCR was downregulated in CHD patients, and its overexpression significantly inhibited HA-VSMCs proliferation and migration via the miR-4731-5p/FOXO3a pathway.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: